EVRG:NASDAQEvergy, Inc. Analysis
Data as of 2026-08-31 - not real-time
$81.02
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Evergy, Inc. is priced at $81.02, and its moving averages give no clean directional read — the structure is neutral. The last 30 days have lost 4.9%. Momentum indicators put RSI at 38.8 (approaching oversold) with MACD reading bearish. Watch $79.85 as support and $84.75 as the nearer resistance level.
The shares look fair, trading on 20.6 times earnings in line with a sector average of 19.2. Consensus targets land 13.5% above where the shares trade now. Revenue is growing at 4.4% on a 15.2% profit margin. The 3.45% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 15.9%, a beta of -0.04 and a maximum drawdown of 8.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 4 out of 10.
The shares look fair, trading on 20.6 times earnings in line with a sector average of 19.2. Consensus targets land 13.5% above where the shares trade now. Revenue is growing at 4.4% on a 15.2% profit margin. The 3.45% dividend yield looks stretched against payout coverage.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 15.9%, a beta of -0.04 and a maximum drawdown of 8.5%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 4 out of 10.
Top Market Events
Evergy Inc EVRG came out with quarterly earnings of $0.Evergy EVRG gave investors fresh information on both income and shareholder returns on 6 August 2026, with second...Detailed price information for Evergy Inc EVRG-Q from The Globe and Mail including charting and trades.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 80.55
- MACD momentum is negative
- RSI at 38.8 is in neutral territory
Medium Term
1–3 yearsNeutral
Model confidence: 4/10
Key Factors
- P/E of 20.6 versus sector average of 19.2
- Dividend yield of 3.45% looks stretched against payout coverage
- Trading above the 200-day average of 80.55
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- P/E of 20.6 versus sector average of 19.2
- Dividend yield of 3.45% looks stretched against payout coverage
- Analyst targets imply +13.5% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth4.40%
Profit Margin15.19%
P/E Ratio20.6
ROE9.25%
ROA2.91%
Debt/Equity160.55
P/B Ratio1.8
Op. Cash Flow$2.0B
Free Cash Flow$-1443362560
Industry P/E19.2
Technical Analysis
TrendNeutral
RSI38.8
Support$79.85
Resistance$84.75
MA 20$82.57
MA 50$84.46
MA 200$80.55
MACDBearish
VolumeStable
Fear & Greed Index94.79
Valuation
Fair Value$21.06
Target Price$91.95
Upside/Downside13.50%
GradeFair
TypeBlend
Dividend Yield3.45%
Risk Assessment
Beta-0.04
Volatility15.88%
Sector RiskLow
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.